← Back to Search

Financial Navigation for Cancer-Related Financial Toxicity

N/A
Recruiting
Led By Stephanie Wheeler, PhD
Research Sponsored by UNC Lineberger Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients must be able to read and speak English
Patients must be able to read and speak English
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 months
Awards & highlights

Study Summary

This trial will study the effects of financial navigation on patients' outcomes in rural and non-rural settings.

Who is the study for?
This trial is for adults over 18 with any type of cancer diagnosed within the last 5 years or living with advanced disease, who are experiencing high financial burden from their care. They must be able to read and speak English and score low on a specific financial toxicity survey.Check my eligibility
What is being tested?
The study tests a program called Financial Navigation designed to help reduce the cost-related stress and impact of cancer treatment. It will compare patient outcomes in rural versus non-rural settings across North Carolina.See study design
What are the potential side effects?
Since this trial involves financial counseling rather than medical intervention, there are no direct physical side effects. However, participants may experience changes in stress levels related to finances.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can read and speak English.
Select...
I can read and speak English.
Select...
I am 18 years old or older.
Select...
I was diagnosed with cancer within the last 5 years or have advanced cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
COST (Comprehensive Score for Financial Toxicity) measure
Secondary outcome measures
Health-Related Quality of Life (HrQoL) Measures

Trial Design

1Treatment groups
Experimental Treatment
Group I: Financial NavigationExperimental Treatment1 Intervention
includes a financial toxicity screening measure (COST), baseline and post-intervention surveys, and approximately 2-6 visits with a financial navigator to identify financial assistance resources

Find a Location

Who is running the clinical trial?

UNC Lineberger Comprehensive Cancer CenterLead Sponsor
348 Previous Clinical Trials
87,391 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,926,615 Total Patients Enrolled
3 Trials studying Tumors
1,244 Patients Enrolled for Tumors
Stephanie Wheeler, PhDPrincipal InvestigatorLineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Media Library

Financial Navigation Clinical Trial Eligibility Overview. Trial Name: NCT04931251 — N/A
Tumors Research Study Groups: Financial Navigation
Tumors Clinical Trial 2023: Financial Navigation Highlights & Side Effects. Trial Name: NCT04931251 — N/A
Financial Navigation 2023 Treatment Timeline for Medical Study. Trial Name: NCT04931251 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there multiple medical centers testing this protocol within the state?

"There are 9 distinct medical sites offering this clinical trial, including The Outer Banks Hospital in Nags Head, Novant Health in Charlotte, and CarolinaEast Health System in New Bern."

Answered by AI

How many individuals are currently taking part in this research project?

"Affirmative, clinicaltrials.gov has verified that this trial is actively seeking participants at 9 locations across the nation, and was initially posted on November 11th of 2021. 780 volunteers are needed to complete the study which was last modified on June 15th 2022."

Answered by AI

Is enrollment for this scientific trial still open to volunteers?

"According to the clinicaltrials.gov records, this trial is still enrolling participants since its inception on November 11th 2021 and last revision on June 15th 2022."

Answered by AI
~97 spots leftby Jul 2024